ℹ️
🇬🇧
Search
Search for publications relevant for "BI 695501"
BI 695501
Publication
Class
Person
Publication
Programmes
publication
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study
2021 |
Central Library of Charles University
